Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...

Apply for a Grant

 

ICRF'S ONLINE APPLICATION SYSTEM
IS NOW OPEN FOR THE 2017-2018
FUNDING YEAR

The Application Deadline for All Grant Categories
except for Acceleration and Project Grants is

December 30, 2016
at 11:59 pm EST

The Pre-Application (LOI) Deadline for
Acceleration and Project Grants is
November 15, 2016
at 11:59 pm EST

♦ ♦ ♦ ♦ ♦

Details on the available ICRF grant categories for the 2017-2018 funding year are listed below:

Please note that with the exception of the International Collaboration and Sabbatical Grant categories, ICRF funds for cancer research are available to citizens of Israel, both native-born and those who have settled.  Funds are not available to visiting scientists.  (Proof of Israeli citizenship must be furnished upon request.) Funds may be requested for clinical or basic research or training, which must relate to cancer and must be conducted in Israel.

 

​"JACKI and BRUCE BARRON
CANCER RESEARCH SCHOLARS’ PROGRAM"

A Partnership Between ICRF and City of Hope, 
generously supported by The Harvey L. Miller Family Foundation

This new program has been established to foster outstanding collaborative research and promote the exchange of ideas between exceptional researchers in the United States and Israel.  The overarching goal of this program is to advance our understanding of cancer and develop life-saving therapies, novel diagnostic approaches and/or prevention strategies by leveraging the knowledge and expertise of scientists in the two countries.  The four interrelated components of the program are: 1) collaborative grants to scientists at City of Hope and in Israel that would meet the highest standards of peer-reviewed research; 2) postdoctoral training at City of Hope for promising young Israeli scientists; 3) sabbaticals for established Israeli scientists at City of Hope and for City of Hope Scientists in Israel; and 4) an annual symposium that would bring researchers from the United States and Israel together to share research discoveries.

To download the application information for this program, please see below:

 

PROJECT GRANTS

For ICRF's 2017-2018 funding year, we have implemented a pre-application (letter of intent or LOI) step for the Project Grants category.  All LOIs must be submitted by November 15, 2016.  Based on the LOIs, a subset of those received will be invited to submit full Project Grant applications and to compete for available funds.  The LOIs should be submitted through the ICRF Online Application System.

These awards are intended to support the research of established investigators. Awards are granted with the understanding that they will support specific projects under the direction of designated principal investigators. Preference is given to persons with more than three years of postdoctoral fellowship or equivalent experience prior to the award commencement date. Awards are made for from one (1) to two (2) years at a maximum stipend of $50,000 per year. (Current Project Grant recipients are encouraged to reapply for continued funding of the same project. Ideally, this should be done during the second year of the award so that, if selected, the new grant will begin upon completion of the old.)

To View, Save, or Print the Project Grant Policies, click here

 

ACCELERATION GRANTS IN CANCER RESEARCH

The Acceleration Grants in Cancer Research, graciously supported by Michael and the late Sally Gordon (z”l), are intended to speed up our understanding of the biology underlying cancer and to provide new knowledge that will rapidly enhance the development of innovative therapeutics.  Grant applications responding to this call must propose highly-innovative approaches that have the promise of pioneering new ways of thinking about cancer biology and therapeutics.  Preliminary data are not a prerequisite, but applicants are encouraged to provide data from disparate sources to support the rationale upon which the new concepts are derived.  While not a requirement, grants that utilize interdisciplinary approaches and that are multi-investigator are encouraged.  Of paramount importance, however, is the novelty of the approach and the promise of accelerating progress to a complete mechanistic understanding of cancer, its management and its cure.  ICRF Acceleration Grants are intended to support the research of established investigators.  The grant is made to an institution with the understanding that it will support a specific project under the direction of a designated principal investigator.  ICRF support under this grant category will only be given to Israeli institutions for work in Israel.  Awarded grants will be for a period of two (2) years, with a funding level of $50,000 per year.

In order to apply for the Acceleration Grants Category, a Letter of Intent (LOI) is required. The LOI should be a one-page summary of the proposed project, formatted for 8.5” x 11” paper with .5” margins. The document may be single or double-spaced, but the font may not be smaller than Arial 11pt.  Along with the LOI, please include the C.V. and publication list for the Principal Investigator (PI) and any Co-PIs or Co-Investigators. The required format is an NIH Biosketch. Only one Letter of Intent per Principal Investigator will be accepted.  All LOIs should be submitted by email to grants@icrfny.org on or before the deadline of November 15, 2016.  A limited number of applicants whose Letters of Intent are deemed most meritorious will be invited to submit full research proposals and compete for the available grants.

To View, Save, or Print the Acceleration Grant Policies, click here

  

PHASE II of the LEN & SUSAN MARK INITIATIVE for OVARIAN and UTERINE/MMMT CANCERS

The Len and Susan Mark Initiative for Ovarian, and Uterine/MMMT Cancers grants are intended to support the research of established investigators studying the biology, diagnosis, treatment, or prevention of ovarian and/or uterine/MMMT cancers.  While not a requirement, grants that utilize interdisciplinary approaches and that are multi-investigator are encouraged.  Grants will be made to an institution or cooperating institutions with the understanding that they will support a specific project under the direction of a designated principal investigator.  ICRF support under this initiative will only be given to Israeli institutions for work in Israel.  Awarded grants will be for a period of three (3) years, with a funding level of approximately $60,000 per year ($180,000 total stipend).

To View, Save, or Print the Policies for Phase II of the Mark Initiative,
click here

 

RESEARCH PROFESSORSHIP

This award will be used to support a full-time, senior faculty member, or person in an equivalent position, who has made outstanding contributions to cancer research and who will continue to provide leadership in his or her research area. The applicant must have at least eight years’ experience beyond the doctoral degree, and be no less than five years from the usual and customary age of retirement at his or her institution. Applicants are expected to provide evidence of past accomplishments and, more importantly, demonstrate potential for continued enriching contributions to the cancer research field. The research experience and interest of the applicant may be in either basic biological science or in clinical research and must relate to cancer. The Research Professorship is awarded for a period of seven (7) years at a maximum stipend of $50,000 per year.

To View, Save, or Print the Research Professorship Policies, click here

 

CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS (CRCDAs)

These awards are intended to enhance the clinical research capabilities of young Israeli scientists in the formative phase of their careers who have demonstrated outstanding potential for contribution to clinical cancer research as independent investigators.  Their main purpose is to provide free time for young medical or pediatric oncologists to devote to clinical research projects and to obtain additional (post-fellowship) training to become a leader in clinical research programs. Candidates must have a medical degree and at least two (2) years of fellowship training in medical or pediatric hematology-oncology or a related specialty, but not more than five (5) years of subsequent relevant professional experience prior to the award commencement date. A CRCDA is limited to a single support period of three (3) years at a maximum stipend of $45,000 per year. (Past recipients are not permitted to reapply for this award.)

To View, Save, or Print the CRCDA Policies, click here

 

RESEARCH CAREER DEVELOPMENT AWARDS (RCDAs)

These awards are intended to enhance the research capabilities of young Israeli scientists in the formative phase of their careers who have demonstrated outstanding potential for contribution to cancer research as independent investigators. Candidates must have a doctoral degree, at least three (3) years of postdoctoral fellowship or equivalent experience, and be within five (5) years of their first appointment to an independent position prior to the award commencement date. Awards are made for three (3) years at a maximum stipend of $35,000 per year. (Recipients are permitted and encouraged to reapply once for an additional three years of support, provided that they are still within five years of their first appointment to an independent position prior to the award commencement date.)  We also have a special program for an RCDA in Pancreatic Cancer.  This grant is made every three (3) years.  Please scroll down for more Information.

To View, Save, or Print the RCDA Policies, click here

 

BARBARA S. GOODMAN ENDOWED RCDA FOR PANCREATIC CANCER

The Israel Cancer Research Fund (ICRF) invites Research Career Development Award (RCDA) applications from interested and eligible investigators studying the biology, diagnosis, treatment, supportive care, and/or prevention of cancer of the pancreas.  The Barbara S. Goodman Endowed RCDA for Pancreatic Cancer has been established as a special grant intended to advance our knowledge of the pathogenesis and treatment of pancreatic cancer.  Candidates must have a doctoral degree, at least three (3) years of postdoctoral fellowship or equivalent experience, and be within five (5) years of their first appointment to an independent position prior to the award commencement date.  Awards are made for three (3) years at a maximum stipend of $35,000 per year. (Recipients are permitted and encouraged to reapply once for an additional three years of support, provided that they are still within five years of their first appointment to an independent position prior to the award commencement date.)  It is anticipated that one (1) new award will be made every three years.

To View, Save, or Print The Barbara S. Goodman Endowed RCDA for Pancreatic Cancer Policies, click here

 

POSTDOCTORAL FELLOWSHIPS

These awards are intended to support young investigators during their postdoctoral training period. Awards are granted with the understanding that they will support specific projects conducted by recent postdoctoral scientists under the supervision of designated sponsoring senior investigators. Preference is given to persons with no more than three years of postdoctoral fellowship or equivalent experience prior to the award commencement date. Applications are also encouraged from M.D.'s who wish to pursue additional investigative work in a laboratory setting to acquire research experience. Awards are made for two (2) years at a maximum stipend of $25,000 per year.  Current Fellowship recipients in the second year of their award desiring continued funding should submit an LOI for a Project Grant.)

To View, Save, or Print the Postdoctoral Fellowship Policies, click here